Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Bayer drops an Ionis-partnered drug after sinking $240M into its development
3 years ago
Deals
R&D
Amgen on IRA's drug price negotiations: 'Material adverse effect' on sales, business and operations
3 years ago
Pharma
After a one-year gap, Sage finally finds new CMO; Gutted by layoffs, Flagship's Rubius reshuffles a not-so-full deck
3 years ago
Peer Review
Sanofi, AstraZeneca clinch first OK for RSV antibody — just as vaccines line up at regulators
3 years ago
Pharma
FDA+
Exclusive: Mt. Everest almost got in the way of a tRNA biotech, but hC Bioscience climbs to Series A extension
3 years ago
Financing
Startups
Scoop: Calling off an IPO, a cancer and Covid-19 vaccine maker raises a Series C
3 years ago
Financing
Startups
'Forward, faster' and 200 jobs lighter as fibrosis and kidney disease get cut, Galapagos CEO Stoffels once again ...
3 years ago
People
Deals
Merck confronts stigma and fear around lung cancer screening in educational campaign
3 years ago
Pharma
Marketing
Regeneron culls two drugs from pipeline amid double-digit revenue drop after Covid mAb cocktail pull
3 years ago
Pharma
With drug price negotiations in the books, Dems turn to launch prices as the next challenge
3 years ago
Law
AstraZeneca pulls patient data exposed on code sharing site GitHub
3 years ago
Pharma
Biopharma companies to FDA: Internationally harmonize plans to standardize safety data and analysis
3 years ago
FDA+
FDA still not ready to go back to actual in-person meetings with biopharma sponsors
3 years ago
FDA+
Moderna's stock plunges in premarket trading as Bancel promises company is in 'much better place' for FY23 deliveries
3 years ago
Pharma
Texas CDMO is cutting 60% of staff as focus shifts to drug discovery, in-house candidates
3 years ago
Pharma
Manufacturing
Manufacturing roundup: Terumo Pharmaceutical Solutions expanding CDMO reach outside Japan; EUROAPI boosting ...
3 years ago
Manufacturing
Updated: Citing efficacy, GSK halts UTI antibiotic trial early, plans to file for FDA approval next year
3 years ago
R&D
Small startup touts a PhIII success in rare 'butterfly skin' disease after an FDA hold routed shares
3 years ago
R&D
Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager
3 years ago
R&D
After pulling IPO plans, Artiva partners with Affimed to speed up NK cell therapy combo
3 years ago
Deals
R&D
'Do the right thing': Billionaire pushes struggling biotech to return cash to investors
3 years ago
People
Exscientia wants to bring its AI/ML approach into the world of biologics. It's starting with antibodies
3 years ago
R&D
AI
Compass' single-dose psilocybin shows strong efficacy in PhII treatment-resistant depression trial
3 years ago
R&D
A Chicago biotech skips the IPO in favor of late-stage Series D for a PhIII Tourette drug
3 years ago
Financing
Startups
First page
Previous page
428
429
430
431
432
433
434
Next page
Last page